1992
DOI: 10.1111/j.1365-4362.1992.tb03984.x
|View full text |Cite
|
Sign up to set email alerts
|

Malignant Spitz Nevus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1996
1996
2010
2010

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 15 publications
0
3
0
Order By: Relevance
“…32 Cases excluded from this study were those that could be included within the so-called malignant Spitz nevus, [33][34][35][36] with partial extirpations, or without 2 or more recorded clinical data; accordingly, 29 cases were excluded.…”
Section: Methodsmentioning
confidence: 99%
“…32 Cases excluded from this study were those that could be included within the so-called malignant Spitz nevus, [33][34][35][36] with partial extirpations, or without 2 or more recorded clinical data; accordingly, 29 cases were excluded.…”
Section: Methodsmentioning
confidence: 99%
“…Indeed, in 1989 and 1992, a group from Armed Forces Institute of Pathology instituted the term ‘metastasizing Spitz nevus,’14, 15 which, due to the identification by a biologic potential (if it metastasizes, it is melanoma), became synonymous in later years with a type of malignant melanoma with Spitz nevus-like cytology, later deemed a Spitzoid melanoma. The entity known as Spitz nevus was first described by Sophie Spitz in 1948,16 denoting these as “melanomas of childhood.” Clinically, these lesions present as benign, small, and asymptomatic superficial skin tumors that are dome-shaped and usually pink or tan, but also sometimes brown or black.…”
Section: Biopathology Of Melanoma In the Pediatric Adolescent And Ymentioning
confidence: 99%
“…The prognosis of spitzoid melanoma in children has been suggested to be better than that observed in adults; however, this assertion remains controversial. Although spitzoid melanomas with regional lymph node metastasis with no further progression have been reported, cases leading to widespread metastasis and fatal outcomes are also well documented 5, 9–11. Due to the rarity of these tumors, large studies with long‐term follow‐up are lacking.…”
mentioning
confidence: 99%